SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-041961
Filing Date
2022-02-14
Accepted
2022-02-14 16:41:22
Documents
2
Group Members
CHART WESTCOTTIKARIAN CAPITAL, LLCNEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d319279dsc13ga.htm SC 13G/A 80241
2 EX-99.1 d319279dex99.htm EX-99 4766
  Complete submission text file 0001193125-22-041961.txt   86614
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88839 | Film No.: 22633460
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A